🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to establish the safety and efficacy of zanubru...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2024-04-19
Trial ID
NCT06350318
Treatments Being Tested
This phase II trial studies the effect of polatuzumab vedotin, venetoclax, ...
Status
Terminated
Location
Siouxland Regional Cancer Center
Start Date
2021-04-01
Trial ID
NCT04659044
Treatments Being Tested
This phase II/III trial tests adding glofitamab to standard of care chemoim...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-30
Trial ID
NCT07724457
Treatments Being Tested
This phase III trial studies rituximab after stem cell transplant and to se...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-11-27
Trial ID
NCT03267433
This phase II/III trial compares the side effects and activity of oral azac...
Status
Active Not Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2021-05-20
Trial ID
NCT04799275
This phase II trial studies whether rituximab and hyaluronidase human (Ritu...
Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2019-06-05
Trial ID
NCT03719131
Treatments Being Tested
This phase III trial compares the effectiveness of rituximab to mosunetuzum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-10-23
Trial ID
NCT06337318
This phase III trial compares the effect of adding pirtobrutinib to the usu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-31
Trial ID
NCT07220187
This study is designed to evaluate the efficacy and safety of acalabrutinib...
Status
Completed
Location
Washington University School of Medicine
Start Date
2018-11-29
Trial ID
NCT03623373
This compares the effects of nivolumab at a fixed dose of 40 mg with chemo-...
Status
Recruiting
Location
National Research Center for Hematology
Start Date
2022-04-01
Trial ID
NCT06188676